VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Fosun Pharmaceutical (600196.SH): HLX48 Injection Receives Clinical Trial Approval
Fosun Pharmaceutical (600196.SH): HLX48 Injection Receives Clinical Trial Approval
May 21, 2026 16:37 CST Updated 17:12
Share:
Fosun Pharmaceutical
Healthcare Industry Group
